The U.S. President aims to increase the pace medical research is done but specialists claim Obama’s precision medicine initiative may not be so precise. They contend it is difficult to change the research arena without reshaping the whole health care system. Barack Obama proclaimed the “precision of medicine” ” on the twentieth of January this year. He reported that the main goal of the mission is to discover and treat the exact kind of malady in patients via genome. The move is supposed to launch a new area in the medical field.
Keith Yamamoto, deputy chancellor of research at the University of California spoke about the advantages brought upon by the “precision of medicine “. He informed that it will permit wellbeing specialists to establish a diagnosis and a cure for each patient independently. Without a doubt, the concept seems rather idealistic. Then again, specialists can without much of a stretch achieve the objective through consistent efforts.
Presently, health experts are using one methodology to treat an expansive number of infections. Accordingly, patients generally encounter severe and even deadly adverse reaction during treatments.
The initial move towards the mission is to structure a national database of genetic profiles. It will allow analysts to review the connection between hereditary traits and medical histories.
Obama’s administration is scheduled to give some initial details about the medical venture this week. Obama said in its State of the Union address he wanted the United States to be the forefront of a new age in medicine, one that offers the right therapy at the right time.
Precision medicine tries to discover and treat the definite type of a disease in patients using their genome data – the exact order of particles in their DNA – together with different variables like the way genes interact with environment, and the microorganisms in their structure.
A 2011 review from a board of the National Academy of Science advised gathering sub-atomic data on a huge number of patients. It likewise required a type 2 diabetes undertaking to spot the amino acids in the blood of individuals who develop the illness, and evaluate how pre-diabetes turns into the real disease. After four years, not one or the studies is being carried. Obama’s drive could revive them, said two board members who asked for anonymity.
Precision medicine has been prompted by advances in cancer studies and pharmacogenomics, the investigation of how DNA responds to medications. Research has shown that ailments, like breast cancer are not uniform, they can be determined by a mixture of hereditary mutations.
Among the bigger organizations in genome sequencing which could gain from Obama’s proposal are Illumina, which recently approved a cooperation with Lockheed Martin on genomics advancement; On the list there are also Thermo Fisher Scientific’s Life Technologies unit and Roche Holding, which in January bought shares worth $1 billion in Foundation Medicine Inc, a pioneer in sequencing tumor genes.
Google and IBM are among huge firms that could assume a part in stocking and translating electronic health records and genomic info.
Image Source: News 724